BioMarin Pharmaceutical

BioMarin is a global biotechnology company that relentlessly pursues bold science to translate genetic discoveries into new medicines that advance the future of human health.

Source: https://www.biomarin.com/company

vosoritideVoxzogo

C-type natriuretic peptide (CNP) analog

Voxzogo (vosoritide) is a C-type natriuretic peptide (CNP) analog from BioMarin for achondroplasia, the most common form of disproportionate short stature. In the United States it increases linear growth in children with open epiphyses, and in the European Union it is used from 4 months of age while growth plates remain open.

Vosoritide is a daily injection that copies C-type natriuretic peptide, a natural growth-promoting signal. In achondroplasia, an overactive FGFR3 sign

1 medicine explained